News

Study results, published in today’s online issue of the New England Journal of Medicine, show that antiretroviral medications taken orally on a daily basis by men who have sex with men can provide partial protection from HIV infection.

The study included 2,499 volunteers in high-risk populations in Brazil, Ecuador, Peru, South Africa, Thailand and the U.S. The study participants were...

Findings from a study, which appear in the October 14, 2010 New England Journal of Medicine, helped influence the World Health Organization (WHO) to change its guidelines this year for the treatment of HIV-infected women who receive a single dose of the antiretroviral drug nevirapine to prevent HIV transmission to their babies. The study demonstrated that the single dose of nevirapine used to...

A Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost vaccine regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa and South America. 

The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), is sponsoring the study,...

Staff at the Kericho Youth Centre (KYC), an NGO supported by the Walter Reed Project – Kenya (WRP), found an inventive and highly successful way to provide training, HIV testing and counseling services to high-risk youth including commercial sex workers and their clients—by going where they go under the cover of darkness.

Along the major highway that runs through the Kericho District in...